Literature DB >> 30405205

Selected Abstracts from the 2018 NCRI Cancer Conference of National Cancer Research Institute.

.   

Abstract

Scottish Event Campus, Glasgow, Sunday 4 - Tuesday 6 November 2018 Attendees of the 2018 NCRI Cancer Conference will be able to contact corresponding authors through the Conference App and e-poster platform at the Conference.W: https://conference.ncri.org.uk : E: conference@ncri.org.ukOrganised by the National Cancer Research Institute, which is a partnership of 19 cancer research funders, the NCRI Cancer Conference provides a platform for researchers, clinicians, people affected by cancer and industry representatives to come together to discuss, present and showcase high-quality research. Sponsorship Statement: Publication of this supplement was sponsored by Roche. All content was reviewed and approved by the NCRI Scientific Committee, which held full responsibility for the abstract selection.

Entities:  

Year:  2018        PMID: 30405205      PMCID: PMC6298386          DOI: 10.1038/s41416-018-0299-z

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  1 in total

1.  Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial.

Authors:  David Dearnaley; Victoria Hinder; Adham Hijab; Gail Horan; Narayanan Srihari; Philip Rich; J Graeme Houston; Ann M Henry; Stephanie Gibbs; Ram Venkitaraman; Clare Cruickshank; Shama Hassan; Alec Miners; Malcolm Mason; Ian Pedley; Heather Payne; Susannah Brock; Robert Wade; Angus Robinson; Omar Din; Kathryn Lees; John Graham; Jane Worlding; Julia Murray; Chris Parker; Clare Griffin; Aslam Sohaib; Emma Hall
Journal:  Lancet Oncol       Date:  2022-03-10       Impact factor: 41.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.